Adial Pharmaceuticals, Inc. (ADIL) vs Cerenome, Inc. (CNSY)

A side-by-side comparison of Adial Pharmaceuticals, Inc. and Cerenome, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Adial Pharmaceuticals, Inc. logo
ADIL
Adial Pharmaceuticals, Inc.
$11M
$4.31HealthcareDelayed quote: Oct 6, 2026, 1:29 PM EDT
Cerenome, Inc. logo
CNSY
Cerenome, Inc.
$11M
$1.57HealthcareDelayed quote: Oct 6, 2026, 1:28 PM EDT

Total return — ADIL vs CNSY

growth of $100 · dividends reinvested · last 1y
ADIL +50.0% (+50.0%/yr)CNSY -61.5% (-61.5%/yr)ADIL compounded faster over this window
50100150200250Start $100$150$39
ADIL CNSY

ADIL vs CNSY: by the numbers

  • •ADIL is the larger company ($11M vs $11M market cap).
  • •Both run net losses; ADIL's is the smaller (0.00% vs -620.70% net margin).

Metrics side by side

Valuation

MetricADILCNSY
P/S ratioN/A2.57
P/B ratioN/A1.98

Profitability

MetricADILCNSY
Gross margin0.00%89.58%
Operating margin0.00%-293.46%
Net margin0.00%-620.70%
ROE-37052.06%-477.54%
ROIC-240.64%-479.39%

Growth (annualized)

MetricADILCNSY
Total return CAGR (5Y)-71.86%N/A

Go deeper

Full ADIL analysisFull CNSY analysisInteractive comparison tool

Dig into the metrics

Adial Pharmaceuticals ROECerenome ROEAdial Pharmaceuticals operating marginCerenome operating marginAdial Pharmaceuticals revenue growthCerenome revenue growthAdial Pharmaceuticals free cash flowCerenome free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.